Shopping For COVID-19 Vaccine Reaches IDR 22.8 Trillion For 121 Million Doses

Illustration (Unsplash)

JAKARTA - Minister of Finance (Menkeu) Sri Mulyani said that the total use of the APBN for the procurement of COVID-19 vaccines had reached Rp. 22.8 trillion. The fund is a recapitulation of the budget until October 2021 for a total of 121.4 million doses.

"Procurement of vaccines is part of the government's expenditure on goods," he said in a virtual press conference on our State Budget, quoted on Friday, November 26.

For information, the realization of the procurement of the COVID-19 vaccine is included in the Health Cluster National Economic Recovery (PEN) program with a total ceiling of Rp. 214.96 trillion.

Meanwhile, the realization of the health cluster itself until November 19, 2021 is known to be worth Rp. 135.53 trillion or 63 percent of the total budget provided.

Several other important sub-sectors included in this cluster are the cost of treating COVID-19 patients, procurement of medicines, incentives for health workers (nakes), and assistance for National Health Insurance (JKN) contributions.

"There are 119.7 million people who have received the first dose of vaccine and 73.7 million people have received the second dose," continued the Minister of Finance.

In addition to the commitment to procure the corona vaccine, state support can also be seen from tax spending through exemption from import duties on vaccines and medical devices, such as PCR test kits, antiviral drugs, and ventilators.

"Fiscal incentives for the import of this vaccine amounted to Rp. 5.42 trillion with similar incentives for importing medical devices of Rp. 1.72 trillion," he said.

Thus, the total value of customs facilities in handling COVID-19 in the country is IDR 7.14 trillion.